返回成功案例
医疗健康

First Coast Mohs has been acquired by AQUA Dermatology

Dermatology and skin cancer specialist First Coast Mohs has partnered with AQUA Dermatology.

First Coast Mohs offers Mohs surgery, surgical and medical dermatology, dermatopathology, cosmetic and laser treatments, electrolysis and other aesthetic services from four state-of-the-art facilities in metro Jacksonville, Florida. The practice features seven clinicians, including two Mohs surgeons, two board certified dermatologists and three Advanced Practice Providers. First Coast Mohs was founded in 2002 by Dr. Scott Warren, who will continue to lead the practice following the transaction.

AQUA Dermatology, backed by Gryphon Investors and GTCR, is the largest dermatology practice in the southeastern United States with over 110 locations and 250 providers. For more than 25 years, the company has treated patients of all ages suffering from skin diseases, acne, sun damage, skin cancer and vein health issues as well as those seeking cosmetic and plastic surgery. With First Coast Mohs, AQUA Dermatology now has 78 locations in Florida.

Oaklins Heritage in Jacksonville served as the intermediary and exclusive financial advisor to the seller in this transaction.

我们的服务
交易方
“The Oaklins Heritage team helped me far beyond my expectations. Their expertise in all aspects of the process, from start to finish, was very detailed and all-encompassing.”

Dr. Scott Warren

Owner, First Coast Mohs

联系交易团队

Daniel Edelman

董事长
杰克逊维尔, 美国
Oaklins Heritage

Dan Curran

董事长
杰克逊维尔, 美国
Oaklins Heritage

Alex Kellison

董事长
杰克逊维尔, 美国
Oaklins Heritage

Mike Bouton

高级分析员
杰克逊维尔, 美国
Oaklins Heritage

相关交易

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
医疗健康

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

更多信息
Creo Medical Group plc has completed a US$15.7 million equity fundraise
医疗健康

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

更多信息
HD Clinical Ltd. has been acquired by NEXUS AG
医疗健康 | 科技、媒体及通讯

HD Clinical Ltd. has been acquired by NEXUS AG

NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.

更多信息